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ABSTRACT In Firmicutes, the nutrient-sensing regulators (p)ppGpp, the effector
molecule of the stringent response, and CodY work in tandem to maintain bacterial
fitness during infection. Here, we tested (p)ppGpp and codY mutant strains of En-
terococcus faecalis in a catheter-associated urinary tract infection (CAUTI) mouse
model and used global transcriptional analysis to investigate the relationship of
(p)ppGpp and CodY. The absence of (p)ppGpp or single inactivation of codY led to
lower bacterial loads in catheterized bladders and diminished biofilm formation on
fibrinogen-coated surfaces under in vitro and in vivo conditions. Single inactivation
of the bifunctional (p)ppGpp synthetase/hydrolase rel did not affect virulence, sup-
porting previous evidence that the association of (p)ppGpp with enterococcal viru-
lence is not dependent on the activation of the stringent response. Inactivation of
codY in the (p)ppGpp0 strain restored E. faecalis virulence in the CAUTI model as
well as the ability to form biofilms in vitro. Transcriptome analysis revealed that
inactivation of codY restores, for the most part, the dysregulated metabolism of
(p)ppGpp0 cells. While a clear linkage between (p)ppGpp and CodY with expression
of virulence factors could not be established, targeted transcriptional analysis indi-
cates that a possible association between (p)ppGpp and c-di-AMP signaling path-
ways in response to the conditions found in the bladder may play a role in entero-
coccal CAUTI. Collectively, data from this study identify the (p)ppGpp-CodY network
as an important contributor to enterococcal virulence in catheterized mouse bladder
and support that basal (p)ppGpp pools and CodY promote virulence through main-
tenance of a balanced metabolism under adverse conditions.
IMPORTANCE Catheter-associated urinary tract infections (CAUTIs) are one of the
most frequent types of infection found in the hospital setting that can develop into
serious and potentially fatal bloodstream infections. One of the infectious agents
that frequently causes complicated CAUTI is the bacterium Enterococcus faecalis, a
leading cause of hospital-acquired infections that are often difficult to treat due to
the exceptional multidrug resistance of some isolates. Understanding the mecha-
nisms by which E. faecalis causes CAUTI will aid in the discovery of new druggable
targets to treat these infections. In this study, we report the importance of two
nutrient-sensing bacterial regulators, named (p)ppGpp and CodY, for the ability of E.
faecalis to infect the catheterized bladder of mice.
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Catheter-associated urinary tract infections (CAUTIs) are one of the most commonhospital-acquired infections, accounting worldwide for about 40% of all nosoco-
mial infections (1–3). In addition to substantially increasing hospitalization time and
costs, CAUTI can lead to serious and potentially deadly secondary bloodstream infec-
tions (4). Complicated CAUTI is often the result of bacteria forming biofilms on
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indwelling urinary catheters, and enterococci (mainly Enterococcus faecalis and Entero-
coccus faecium) appear as the second leading cause of complicated CAUTI in many
health care facilities (4–6). In addition, E. faecalis and E. faecium are major etiological
agents of other life-threatening infections, such as infective endocarditis, and an even
more serious threat to public health due to their exceptional antibiotic resistance (7).
The recent rise in the number of enterococcal infections urges the development of new
therapies, and understanding the mechanisms that promote E. faecalis CAUTI might
uncover new druggable targets.
The pathogenic potential of E. faecalis, and of all enterococci in general, is tightly
associated with its outstanding ability to survive an array of physical and chemical
stresses, including common detergents and antiseptics; fluctuations in temperature,
pH, and humidity; and prolonged starvation (7). The regulatory second messengers
ppGpp (guanosine tetraphosphate) and pppGpp (guanosine pentaphosphate), collec-
tively known as (p)ppGpp, broadly promote bacterial stress tolerance and virulence (8,
9). In E. faecalis, (p)ppGpp has been shown to promote virulence in invertebrate and
vertebrate animal models and to mediate the expression of virulence-related traits such
as growth in blood and serum, biofilm formation, intraphagocytic survival, and antibi-
otic tolerance (10–17). Originally described as the mediator of the stringent response
(SR) (8), (p)ppGpp has distinct effects on bacterial physiology: at low (basal) concen-
trations, it fine-tunes bacterial metabolism to adjust cellular growth in response to mild
environmental changes (18), whereas at high levels, it activates the SR responsible for
promoting cell survival by slowing down growth-associated pathways and activating
stress survival pathways (8, 18).
Two enzymes, the bifunctional synthetase/hydrolase Rel and the small alarmone
synthetase RelQ, are responsible for enterococcal (p)ppGpp turnover (10, 19). Despite
both Δrel and Δrel ΔrelQ strains being unable to mount the SR (10, 13), there are
fundamental differences in basal (p)ppGpp levels between these two strains. Specifi-
cally, while the double mutant, here called the (p)ppGpp0 strain, is completely unable
to synthesize (p)ppGpp, basal (p)ppGpp levels are about 4-fold higher in the Δrel strain
due to the constitutive and weak synthetase activity of RelQ (10, 14, 19). Accumulated
evidence indicates that the metabolic control exerted by basal (p)ppGpp pools is more
important during enterococcal infections than the semidormancy state characteristic of
the SR (10, 13–17). This is exemplified by the distinct virulence phenotypes of Δrel and
(p)ppGpp0 strains, both of which are unable to mount the SR. Specifically, while only
the (p)ppGpp0 strain displayed attenuated virulence in Caenorhabditis elegans (10),
Galleria mellonella (11, 13, 16), and a rabbit abscess model (15), the Δrel single mutant
strain showed attenuated virulence in a rabbit model of infective endocarditis (17).
In low-GC Gram-positive bacteria such as E. faecalis, (p)ppGpp controls the tran-
scription of nutrient uptake and amino acid biosynthesis genes via the branched-chain-
amino-acid (BCAA)- and GTP-sensing CodY regulator (20). It follows that (p)ppGpp
accumulation during BCAA starvation severely depletes intracellular GTP pools in all
Firmicutes such that CodY regulation is severely impaired due to the depletion of its two
cofactors (20). We recently confirmed the existence of the (p)ppGpp-CodY network in
E. faecalis and demonstrated that inactivation of codY restored several phenotypes of
the (p)ppGpp0 mutant strain, including virulence in G. mellonella (16). However, the
contribution of the global nutritional regulator CodY to enterococcal pathogenesis in
mammalian hosts remains unknown.
In this work, we examined the contribution of (p)ppGpp and CodY to the patho-
genesis of E. faecalis in a murine CAUTI model (21). We discovered that, separately,
basal levels of (p)ppGpp and the transcriptional regulator CodY promote biofilm
formation in urine under in vitro conditions as well as virulence in a murine CAUTI
model. Global transcriptome analysis validates previous findings that deletion of codY
restores, at least in part, the dysregulated metabolism of the cell in the absence of
(p)ppGpp. Finally, targeted mRNA quantifications reveal that the (p)ppGpp-CodY net-
work alters the expression of genes coding for cyclic di-AMP (c-di-AMP) biosynthetic
enzymes and of CAUTI virulence factors. Altogether, data from this study identify the
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(p)ppGpp-CodY network as a contributor to enterococcal catheter colonization in the
urinary tract and further support that basal levels of (p)ppGpp promote bacterial
virulence through maintenance of a balanced bacterial metabolism.
RESULTS
The (p)ppGpp0 and codY strains show impaired colonization in a murine
CAUTI model. We compared the abilities of the E. faecalis OG1RF parent, Δrel, ΔrelQ,
(p)ppGpp0, ΔcodY, and (p)ppGpp0 ΔcodY strains to colonize and persist in the bladder
of catheterized mice. Briefly, catheters were implanted into the bladders of C57BL/6Ncr
mice prior to transurethral inoculation with 2  107 CFU of each designated strain. At
3 days postinfection, the OG1RF strain was readily recovered from bladders (6.3  0.6
log10 CFU) and catheters (6.0  0.3 log10 CFU) of all infected animals (Fig. 1). Inactiva-
tion of rel (Δrel) or relQ (ΔrelQ) did not significantly alter E. faecalis colonization in
bladders, but the level of recovery of ΔrelQ bacteria from catheters was significantly
lower (0.8-log10 reduction; P  0.0027 compared to OG1RF). On the other hand, the
(p)ppGpp0 strain displayed 0.8-log10 (P  0.0015) and 1.5-log10 (P  0.0001) reduc-
tions in CFU recovered from bladders and catheters, respectively (Fig. 1). The ΔcodY
strain phenocopied the (p)ppGpp0 strain, showing 0.8-log10 reductions in CFU recov-
ered from both bladders (P  0.0156) and catheters (P  0.0031) (Fig. 1). However,
inactivation of codY in the (p)ppGpp0 background [(p)ppGpp0 ΔcodY triple mutant]
restored bacterial bladder and catheter colonization to near-parent-strain levels. De-
spite great variations from animal to animal but in relative agreement with the bacterial
loads detected on catheters and in bladders, the OG1RF and Δrel strains were consis-
tently able to ascend to the kidneys (Fig. 1C). However, the (p)ppGpp0 ΔcodY triple
mutant failed to consistently ascend to the kidneys, suggesting that the virulence of
this strain may be partially compromised.
(p)ppGpp promotes timely growth of E. faecalis in human urine. The (p)ppGpp0
strain was previously shown to have growth and survival defects in whole blood and
serum (15, 16). Interestingly, inactivation of codY in the (p)ppGpp0 background
[(p)ppGpp0 ΔcodY] restored the (p)ppGpp0 growth defect in blood but not in serum
(16). Here, we tested the ability of (p)ppGpp-defective [Δrel, ΔrelQ, and (p)ppGpp0] and
codY [ΔcodY and (p)ppGpp0 ΔcodY] strains to replicate in pooled human urine ex vivo.
Despite the colonization defect in the murine CAUTI model (Fig. 1), the ΔcodY strain
grew as well as the parent and ΔrelQ strains (Fig. 2). On the other hand, Δrel, (p)ppGpp0,
and (p)ppGpp0 ΔcodY strains grew slower in the first 12 h of incubation, with an
0.6-log10 CFU difference at 3 and 7 h postinoculation (Fig. 2). Nevertheless, upon
FIG 1 (p)ppGpp and CodY promote virulence of E. faecalis in a murine CAUTI model. The parent strain OG1RF and its derivatives were inoculated
into the bladders of mice immediately after catheter implantation (n  10). After 72 h, animals were euthanized, and bacterial burdens in bladders
(A), catheters (B), and kidneys (C) were quantified. Graphs show total CFU recovered from these sites, each symbol represents an individual mouse,
and the median value is shown as a horizontal line. Symbols on the dashed line indicate that recovery was below the limit of detection (LOD)
(40 CFU). The data were pooled from two independent experiments. Two-tailed Mann-Whitney U tests were performed to determine significance
(*, P  0.05; **, P  0.005; ****, P  0.0001).
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entering stationary phase, all strains reached similar growth yields and remained viable
for at least 24 h.
(p)ppGpp and CodY support biofilm formation in urine. Biofilm formation on
urinary catheters is critical for enterococcal CAUTI (22–24). This is exemplified by the
observation that E. faecalis OG1RF requires the presence of a catheter to persist for
more than 48 h in murine bladders (21). Follow-up studies revealed that catheterization,
in mice and in humans, triggers an inflammatory response that releases the host
protein fibrinogen, which is used by E. faecalis as a nutrient as well as a scaffold to
adhere to and colonize the catheter surface (22–25). Taking into account that the
reduction in bacterial counts of ΔrelQ, (p)ppGpp0, and ΔcodY strains was more pro-
nounced on catheters than in bladders (Fig. 1) and that (p)ppGpp supports long-term
survival of E. faecalis in biofilms (12), we sought to investigate if the attenuated
virulence of these strains in murine CAUTI was linked to a reduced ability to form
biofilms on fibrinogen-coated surfaces in the presence of urine. Since catheterization
normally elicits proteinuria in the host, and E. faecalis requires a protein source to
optimally form biofilms in urine (22, 24), human urine was supplemented with bovine
serum albumin (BSA). In agreement with the bacterial loads obtained from the im-
planted catheters (Fig. 1B), quantifications of E. faecalis biofilm biomass revealed that
ΔrelQ, (p)ppGpp0, and ΔcodY strains were deficient in biofilm production, while the Δrel
strain phenocopied the parent OG1RF strain (Fig. 3A). Notably, inactivation of codY in
the (p)ppGpp0 background alleviated the defective phenotype of the (p)ppGpp0 strain,
albeit the differences between the (p)ppGpp0 ΔcodY and OG1RF strains were still
statistically significant.
As indicated above, the main factor involved in E. faecalis biofilm formation on
urinary catheters is the production of the Ebp pilus, which binds directly to fibrinogen
via the EbpA N-terminal domain (22, 26, 27). Quantification of EbpA via an enzyme-
linked immunosorbent assay (ELISA) showed no noticeable reductions in EbpA pro-
duction in any of the mutant strains (Fig. 3B), suggesting that the (p)ppGpp-CodY
network promotes biofilm formation of fibrinogen-coated surfaces in an Ebp-
independent manner.
Inactivation of codY restores the dysregulated metabolism of the (p)ppGpp0
strain. Previously, we proposed that the virulence attenuation of the (p)ppGpp0 strain
FIG 2 (p)ppGpp supports timely growth of E. faecalis in human urine. Growth of the parent E. faecalis
strain OG1RF and its derivative mutant strains in pooled human urine was analyzed. Aliquots at selected
time points were serially diluted and plated onto TSA plates for CFU enumeration. The graph shows the
average log10-transformed CFU (means and standard deviations) from three independent experiments.
Mutant strains were compared to wild-type (wt) strain OG1RF by two-way ANOVA with Dunnett’s
multiple-comparison test. Asterisks indicate significant differences at 3 h of incubation for the Δrel,
(p)ppGpp0, and (p)ppGpp0 ΔcodY strains and at 7 h of incubation for the Δrel and (p)ppGpp0 ΔcodY
strains (P  0.0001).
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in different animal models is, in large part, due to the dysregulated metabolism caused
by a lack of (p)ppGpp control (13, 14, 16). By monitoring H2O2 production and the
culture pH, we provided the first evidence that inactivation of codY restored a balanced
metabolism to the (p)ppGpp0 background strain (16). To obtain additional insights into
the (p)ppGpp-CodY relationship, we used RNA sequencing (RNA-seq) technology to
compare the transcriptomes of OG1RF, (p)ppGpp0, and (p)ppGpp0 ΔcodY strains grown
to mid-exponential phase in chemically defined FMC medium (28) supplemented with
10 mM glucose (FMCG medium). In the (p)ppGpp0 strain, 690 genes were differentially
expressed compared to OG1RF (P  0.05; 2-fold cutoff) (see Table S1 in the supple-
mental material), representing 27% of the entire E. faecalis OG1RF genome. In
agreement with a previous microarray analysis (14), multiple phosphotransferase sys-
tems (PTSs) as well as citrate, glycerol, malate, and serine utilization pathways were
strongly induced in the (p)ppGpp0 strain under these conditions. A selected and
representative number of dysregulated transport and metabolic genes in the
(p)ppGpp0 strain are shown in Tables 1 and 2, respectively. The upregulation of
alternate carbon metabolism genes that are expected to be under carbon catabolite
repression (CCR) under the glucose-rich conditions of FMCG medium indicates that a
complete lack of (p)ppGpp places E. faecalis in what we have originally termed a
“transcriptionally relaxed” state (14). Compared to the parent strain, 737 genes (29%
of the entire genome) were differentially expressed in the (p)ppGpp0 ΔcodY triple
mutant strain (P  0.05; 2-fold cutoff) (Table S2). Despite the even larger number of
differentially expressed genes, inactivation of codY in the (p)ppGpp0 background strain
normalized the transcription of 274 genes that were dysregulated in the (p)ppGpp0
background (Table S3). The great majority (95%) of these genes were upregulated in
the (p)ppGpp0 strain, supporting that deletion of codY abrogates, at least in part, the
transcriptionally relaxed state of the (p)ppGpp0 mutant. More specifically, inactivation
of codY in the (p)ppGpp0 background normalized the transcription (or brought it to
levels much closer to that of the parent strain) of 70 transport systems as well as over
130 metabolic genes, including citrate, glycerol, malate, and serine utilization pathways;
dehydrogenases; and molybdenum-dependent enzymes (Table S3).
Dysregulation of c-di-AMP homeostasis may affect fitness of (p)ppGpp0 and
codY strains in urine. Previously, the Ebp pilus and two high-affinity manganese
transporters, EfaCBA and MntH2, were shown to be essential for E. faecalis virulence in
FIG 3 The (p)ppGpp-CodY network contributes to biofilm formation in urine. (A) Fibrinogen-coated
96-well polystyrene plates were incubated with E. faecalis strains for 48 h in human urine supplemented
with 20 mg ml1 BSA. Plates were stained with 0.5% crystal violet, which was subsequently dissolved
with 33% acetic acid, and the absorbance at 595 nm was measured. (B) EbpA quantification in urine.
Strains were grown in urine plus BSA overnight prior to quantification of EbpA by an ELISA. EbpA surface
exposure on E. faecalis cells was detected using mouse anti-EbpAFull and HRP-conjugated goat anti-rabbit
antisera, and the absorbance was determined at 450 nm. EbpA production titers were normalized against
the bacterial titers. Experiments were performed independently in triplicate and analyzed by a two-tailed
Mann-Whitney U test (*, P  0.05; ****, P  0.0001).
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a mouse CAUTI model (27, 29). In an attempt to identify (p)ppGpp- and CodY-
dependent processes directly relevant to enterococcal CAUTI, we compared the tran-
scriptional profiles of these virulence factors in parent and mutant strains. In brief,
quantitative real-time PCR (qPCR) was used to compare expression levels of selected
genes in exponentially grown brain heart infusion (BHI) broth cultures of OG1RF, ΔcodY,
(p)ppGpp0, and (p)ppGpp0 ΔcodY strains before and after switching the cultures to
pooled human urine. We found that the transcription of ebpA (coding for the pilin
subunit), efaC (the ATP-binding subunit of the ABC-type transporter EfaCBA), and
mntH2 was strongly induced upon shifting the parent strain culture from BHI broth to
urine (Fig. 4). While full upregulation of efaC in urine appears to be dependent on CodY,
ebpA and mntH2 transcription was differentially impacted by (p)ppGpp and CodY.
Specifically, while inactivation of CodY (ΔcodY) limited the induction of these genes
after transition to urine, the loss of (p)ppGpp induced the transcription of ebpA and
TABLE 1 Transcriptional restoration of selected nutrient transport systems upon
inactivation of codY in the (p)ppGpp0 background














bglP PTS, -glucoside uptake 7.4
frwB PTS, fructose uptake 11.5
malX PTS, maltose uptake 4.7
mltF2 PTS, mannitol uptake 7.1
scrA PTS, -glucoside uptake 3.4
sorA PTS, sorbose uptake 32.5
treB PTS, trehalose uptake 11.9 2.0
ulaB PTS, ascorbate uptake 5.1
ABC-type transporters
OG1RF_10665 ABC-type transporter 3.4 2.5
OG1RF_10879 ABC-type transporter 2.2
OG1RF_11003 ABC-type transporter 15.9
OG1RF_11188 ABC-type transporter 8.1
OG1RF_11763 ABC-type transporter 3.2
OG1RF_11774 Sugar ABC-type transporter 38.5
OG1RF_12466 ABC-type transporter 3.5
mdlB Multidrug ABC-type transporter 3.2
modB Molybdenum transporter 31.5
T0 Oligopeptide transporter 3.3
ziaA Zinc ABC-type transporter 3.2
Other porters
OG1RF_11781 Sodium symporter 5.3
OG1RF_11873 Phosphate transporter 4.5 2.5
OG1RF_11954 Xanthine/uracil permease 3.0
OG1RF_12019 Gluconate symporter 4.7
OG1RF_12274 Major facilitator transporter 21.3
OG1RF_12280 Cytosine/purine permease 5.4
OG1RF_12572 Citrate transporter 51.8
dctM Organic acid transporter 4.5
glpF2 Glycerol uptake 11.0
aValues represent fold changes in transcription compared to the parent strain. All values shown were
statistically significant (P  0.05). Blank fields indicate that there were no significant differences between
mutant and parent strains.
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mntH2 by 10-fold. The simultaneous inactivation of codY in the (p)ppGpp0 back-
ground [(p)ppGpp0 ΔcodY] modestly raised ebpA but fully restored mntH2 mRNA levels
(Fig. 4).
We also assessed transcription levels of genes coding for enzymes involved in the
metabolism of c-di-AMP, a nucleotide second messenger essential for osmotic stress
survival and whose regulatory network appears to be intertwined with the (p)ppGpp
regulatory network in other bacteria (30–34). In the OG1RF strain, transcription of the
c-di-AMP cyclase cdaA was not significantly altered upon transition from BHI broth to
urine; however, transcription of both c-di-AMP hydrolases (pde and gdpP) was induced
by 50- and 100-fold, respectively (Fig. 4). While induction of gdpP was dependent on
CodY, activation of pde in urine was not as robust in all mutant strains. Unexpectedly,
TABLE 2 Transcriptional profile of selected metabolic genes upon inactivation of codY in
the (p)ppGpp0 background




OG1RF_10979 Citrate carrier 31.2
citC Citrate metabolism 17.0 5.0
citD Citrate metabolism 18.7 3.3
citE Citrate metabolism 15.6 5.0
citF Citrate metabolism 15.0 5.0
citX Citrate metabolism 13.4 5.0
citXG Citrate metabolism 13.2 2.0
Serine metabolism
sdaA Serine dehydratase 103.5
sdaB Serine dehydratase 94.5 2.5
Glycerol metabolism
glpK Glycerol kinase 5.7 2.5
glpO Glycerol-3-phosphate oxidase 6.6 2.5
gldA2 Glycerol dehydrogenase 13.7
Molybdenum metabolism
OG1RF_11183 MOSC proteinb 30.1
OG1RF_11185 Molybdopterin-binding protein 25.6
OG1RF_11944 Molybdenum hydroxylase 29.7
OG1RF_11951 Molybdenum hydroxylase 10.8 2.0
moaA Molybdenum cofactor synthesis 20.0
moaB Molybdenum cofactor synthesis 27.1
moaC Molybdenum cofactor synthesis 10.1
yedF2 Selenium metabolism 23.3
ygfJ Molybdenum hydroxylase 20.6
Other metabolic genes
OG1RF_11942 Ferredoxin NADP reductase 23.4
OG1RF_11943 Flavodoxin 20.7
allD Ureidoglycolate dehydrogenase 14.7
mdh Malate dehydrogenase 16.5
fbp Fructose-1,6-bisphosphatase 10.6 3.9
oadA Oxaloacetate decarboxylase 14.2 3.3
OG1RF_10107 Glycosyl hydrolase 60.1
gcdB Glutaconyl-CoA decarboxylase 15.0 5.0
arcC2 Carbamate kinase 17.4
gltA Glutamate synthase 16.8
OG1RF_11949 Cysteine desulfurase 25.7 2.5
hydA Dihydropyrimidinase 14.6
OG1RF_11585 Ribosylpyrimidine nucleosidase 11.1 3.3
OG1RF_10108 Endoribonuclease 48.7
endOF3 N-Acetylglucosaminidase 60.1
aValues represent fold changes in transcription compared to the parent strain. All values shown were
statistically significant (P  0.05). Blank fields indicate that there were no significant differences between
mutant and parent strains.
bMOSC, MOCO (molybdenum cofactor) sulfurase C-terminal.
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cdaA transcription was strongly induced (50-fold) in the (p)ppGpp0 strain when
shifted from BHI broth to urine, suggesting that c-di-AMP levels may be dysregulated
in the (p)ppGpp0 strain during CAUTI. Notably, pools of c-di-AMP must be tightly
controlled given that it is essential for growth but also highly toxic when present at
high concentrations (35).
DISCUSSION
In this report, we show that basal (p)ppGpp pools and the transcriptional regulator
CodY mediate the virulence of E. faecalis in a murine CAUTI model. These results
corroborate previous findings that changes in basal levels of (p)ppGpp contribute to
the virulence of E. faecalis (10, 11, 13, 15, 17) and show, for the first time, that CodY
regulation is also important for the virulence of E. faecalis. Despite the attenuated
virulence of the ΔcodY, ΔrelQ, and (p)ppGpp0 strains, simultaneous inactivation of both
regulatory pathways [(p)ppGpp0 ΔcodY strain] restored virulence to near-parent-strain
levels. While this finding may appear contradictory, it is in line with previous studies
showing that inactivation of codY restores the virulence of (p)ppGpp0 strains of Listeria
monocytogenes and Staphylococcus aureus (36, 37).
Despite the significance of the (p)ppGpp-CodY regulatory network in enterococcal
CAUTI, the differences in total bacteria recovered from the infected organs observed
here were not as robust as those observed in a previous investigation that depicted the
essential role of the manganese transporters EfaCBA and MntH2 in CAUTI (29). Inter-
estingly, we have shown that several phenotypes of the (p)ppGpp0 strain can be
reverted by manganese supplementation, which is used to help the cells cope with
high levels of endogenously produced reactive oxygen species (ROS) (16). Thus, it is
conceivable that the attenuated virulence of the (p)ppGpp0 strain shown here can
FIG 4 Transcript levels of selected genes in OG1RF, (p)ppGpp0, ΔcodY, and (p)ppGpp0 ΔcodY cultures in BHI broth or human urine. The E. faecalis OG1RF
wild-type (WT), (p)ppGpp0, (p)ppGpp0 ΔcodY, and ΔcodY strains were grown in BHI broth to the mid-exponential growth phase. Cell pellets were washed
thoroughly and then exposed to pooled human urine and fresh BHI broth for 30 min. The transcript levels of ebpA (A), efaC (B), mntH2 (C), cdaA (D), pde (E),
and gdpP (F) were determined by quantitative real-time PCR. The bar graphs show averages and standard deviations of results from three independent
experiments performed in triplicate. Differences seen with the same strains under different conditions (#) or between parent and mutant strains under the same
growth conditions (*) were compared via Student’s t test or ANOVA with a multiple-comparison test, respectively (P  0.05).
Colomer-Winter et al.
July/August 2019 Volume 4 Issue 4 e00392-19 msphere.asm.org 8
 on A











be traced to manganese homeostasis and thereby restored in mice fed a high-
manganese diet or in animals that are unable to sequester manganese during infection
(calprotectin-defective mice).
The association between (p)ppGpp and CodY, by which (p)ppGpp upregulates gene
transcription via GTP depletion and the concomitant alleviation of CodY repression, has
been well established (20). We previously found that the (p)ppGpp and CodY regulatory
networks are also intertwined in E. faecalis by showing that inactivation of codY
restored phenotypes of the (p)ppGpp0 strain, such as the inability to grow in whole
blood ex vivo and reduced virulence in the G. mellonella invertebrate model (16). By
comparing final culture pH and H2O2 production of (p)ppGpp0 and (p)ppGpp0 ΔcodY
strains, we hypothesized that deletion of codY restores a balanced metabolism to the
(p)ppGpp0 strain (14, 16). The RNA-seq analysis reported here clearly supports this
observation, as multiple genes coding for alternate carbon utilization pathways were
strongly upregulated in the (p)ppGpp0 strain but not in the (p)ppGpp0 ΔcodY triple
mutant strain.
Our results also indicate that restoration of global metabolism in the (p)ppGpp0
ΔcodY strain compared to the (p)ppGpp0 strain may be particularly relevant in exper-
imental CAUTI. Specifically, we show that while the absence of either (p)ppGpp or CodY
results in defects in biofilm formation in vitro and in vivo, simultaneous inactivation of
the (p)ppGpp and CodY regulatory systems restores CAUTI virulence and partially
restores in vitro biofilm formation to near-parent-strain levels (Fig. 1 and 3). Considering
that the levels of the surface protein EbpA were not altered in any of the mutant strains
(Fig. 3), we propose that (p)ppGpp and CodY promote biofilm formation on urinary
catheters by mediating the metabolic rearrangements required for biofilm growth
and survival in urine. In fact, a comparative transcriptome analysis reveals that
several metabolic pathways previously identified as being relevant to enterococcal
adaptation to growth in urine (38) overlap the (p)ppGpp and CodY regulons (13, 14,
20). For example, transcriptional activation of alternate carbon utilization and
amino acid biosynthesis/transport genes in response to the relatively low urinary
concentrations of amino acids and glucose (38–41) is shown here to be regulated
by (p)ppGpp and CodY (Tables 1 and 2; see also Table S1 in the supplemental
material) (13, 14, 20).
In an attempt to identify specific (p)ppGpp- and CodY-regulated processes that are
important for CAUTI, we used qPCR to compare transcription levels of known virulence
factors, such as the Ebp pilus and the metal transporters EfaCBA and MntH2 (27, 29), in
parent and mutant strains. Although there were significant alterations in the transcrip-
tion of ebpA, efaC, and mntH2 in the (p)ppGpp and codY mutant strains, it was not
possible to establish a firm correlation between the transcriptional expression of these
virulence factors and the attenuated virulence phenotypes shown in Fig. 1. Due to the
association of c-di-AMP signaling with biofilm formation (33, 34) and adaptation to
osmotic stress (31, 32), two relevant traits during CAUTI, and the previous linkage with
(p)ppGpp signaling (30, 35, 42), we similarly assessed gene expression of the enzymes
responsible for c-di-AMP synthesis (cdaA) and degradation (pde and gdpP). c-di-AMP is
an emerging regulatory nucleotide shown to control a number of cellular processes,
including potassium homeostasis, osmotic adaptation, and biofilm formation (35). In
addition, previous investigations revealed an intricate but poorly understood associa-
tion between the c-di-AMP and (p)ppGpp signaling networks, in which (p)ppGpp
regulates c-di-AMP levels by serving as an allosteric regulator of c-di-AMP phosphodi-
esterase (PDE) enzymes, while c-di-AMP stimulates (p)ppGpp synthesis via an unknown
mechanism (30, 35, 42). The strong activation of pde and gdpP in the parent strain upon
a shift to urine suggests that intracellular c-di-AMP levels decrease in the presence of
urine. This is not surprising considering that salt concentrations in urine are generally
high (average osmolarity of between 300 and 900 mosM/kg H2O) and that low
c-di-AMP levels are associated with bacterial salt tolerance (43), whereas increased
c-di-AMP levels are linked to salt hypersensitivity (44–46). Interestingly, the level of
transcription of the c-di-AMP synthetase gene (cdaA) in urine was approximately
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100-fold higher in the (p)ppGpp0 strain than in the parent strain, indicating that
c-di-AMP homeostasis may be severely disrupted in the (p)ppGpp0 strain. Finally,
transcription of the pde and gdpP genes was not as strongly induced (or not induced
at all) in the (p)ppGpp0 and ΔcodY strains. While the cellular levels of c-di-AMP in cells
grown in urine remain to be determined, and the possibility of (p)ppGpp/c-di-AMP
signaling cross talk in E. faecalis remains to be confirmed, the qPCR analysis suggests
that E. faecalis decreases c-di-AMP pools to adjust its metabolism to the environment
(i.e., high osmolality) encountered in urine.
By comparing the genes restored by codY inactivation in our RNA-seq analysis
(Tables 1 and 2 and Table S1) to the transcriptome of E. faecalis OG1RF grown in urine
(38), several other common pathways were identified, providing additional leads as to
why alleviation of CodY repression restored the biofilm defect of the (p)ppGpp0 strain.
Specifically, Vebø et al. showed that transcription of a major glycerol uptake system was
induced when the OG1RF strain was grown in urine ex vivo, suggesting that E. faecalis
utilizes glycerol as a source of energy to grow and survive in urine (38). Notably, aerobic
metabolism of glycerol by the GlpO enzyme is also the main source of H2O2 generation
in E. faecalis (47), and E. faecalis activates the transcription of several oxidative genes
(such as sodA, npr, and trxB) when grown in urine (38), possibly to cope with increased
ROS generation caused by aerobic glycerol metabolism. In agreement with previous
microarray data (14), the current RNA-seq analysis revealed that transcription of glyc-
erol catabolic genes, such as glpO and gldA2, was activated by 6-fold or more in the
(p)ppGpp0 strain (Table 2 and Table S1), likely augmenting ROS production in the
urinary tract. Another possibility, which is not mutually exclusive from the others, is
that the strong (20-fold) upregulation of molybdenum metabolism genes in the
(p)ppGpp0 strain is disadvantageous to E. faecalis when grown in the urinary tract
environment. Molybdenum is a rare transition metal that functions as a cofactor of
several redox-active enzymes (48–50); it should be noted that urothione, the degrada-
tion product of the molybdenum cofactor in humans, is excreted in urine (51). In
contrast to other metal cofactors, molybdenum is catalytically active only when com-
plexed with a pterin-based scaffold, forming the Moco prosthetic group (50). The Moco
biosynthetic genes that are highly induced in the (p)ppGpp0 mutant strain code for
enzymes that require GTP and the oxygen-reactive iron and copper metals (50),
possibly linking molybdenum metabolism to (p)ppGpp and oxidative stress. Finally, E.
faecalis appears to downregulate serine catabolism in urine (38). However, serine
dehydratases were among the most highly expressed genes in the (p)ppGpp0 strain
(100-fold), likely favoring pyruvate generation instead of protein synthesis. While it is
unknown how serine catabolism and dysregulation of other metabolic and transport
pathways affect biofilm formation and virulence in E. faecalis, alleviation of CodY
repression for the most part restored the transcription of these genes to wild-type
levels.
Collectively, the results presented here reveal that (p)ppGpp and CodY support the
presence of E. faecalis in the catheterized murine urinary tract by controlling the
metabolic arrangements necessary for the fitness of E. faecalis in this environment and,
possibly, by modulating biofilm formation. Future studies using global transcriptome
and metabolome analyses of (p)ppGpp-deficient and CodY-deficient strains recovered
directly from CAUTI, coupled with characterization of pathways relevant to biofilm
formation in urine, are necessary to fully understand how alleviation of CodY repression
restores biofilm formation in the absence of (p)ppGpp. In addition, the relevance of
c-di-AMP signaling to enterococcal CAUTI and the relationship between (p)ppGpp and
c-di-AMP signaling pathways will warrant further investigations. In this regard, work is
under way to determine the scope and targets of c-di-AMP regulation in E. faecalis.
These studies should expand our mechanistic understanding of how global metabolic
regulators such as CodY, (p)ppGpp, and possibly c-di-AMP mediate enterococcal patho-
genesis in the urinary tract and beyond.
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Bacterial strains and growth conditions. The parent E. faecalis OG1RF strain and its derivative Δrel,
ΔrelQ, Δrel ΔrelQ [(p)ppGpp0], ΔcodY, and (p)ppGpp0 ΔcodY strains were previously described (10, 16). All
strains were routinely grown in BHI broth at 37°C. For RNA sequencing (RNA-seq) analysis, cultures of E.
faecalis OG1RF, (p)ppGpp0, and (p)ppGpp0 ΔcodY strains grown overnight were diluted in a 1:100 ratio
in 50 ml of chemically defined FMC medium (28) supplemented with 10 mM glucose (FMCG medium)
and allowed to grow statically at 37°C to an optical density at 600 nm (OD600) of 0.3. Growth in pooled
human urine from healthy donors (Lee Biosolutions) was monitored as described previously, with minor
modifications (29). Briefly, cultures grown overnight were diluted 1:100 in phosphate-buffered saline
(PBS) and inoculated at a 1:100 dilution for growth assessment in urine. Cultures were incubated
aerobically at 37°C, and at selected time points, aliquots were serially diluted and plated onto tryptic soy
agar (TSA) plates for CFU determination. To determine the transcriptional responses of selected genes
upon transition from laboratory medium to human urine, cultures grown overnight in BHI broth were
diluted 1:20 in 5 ml of fresh sterile BHI broth and allowed to grow statically at 37°C to an OD600 of 0.5.
The bacterial cells were washed twice with PBS (pH 7.0) and pelleted down by centrifugation at
2,500 rpm for 8 min. After washing, pellets were resuspended in 7.5 ml filter-sterilized urine and incu-
bated at 37°C for 30 min. The controls were resuspended in the same volume of fresh BHI broth and
incubated at 37°C for 30 min.
Mouse catheter implantation and infection. The mice used in this study were 6-week-old female
wild-type C57BL/6Ncr mice purchased from Charles River Laboratories. Mice were subjected to trans-
urethral implantation and inoculated as previously described (21). Mice were anesthetized by inhalation
of isoflurane and implanted with a 5-mm-long platinum-cured silicone catheter. When indicated, mice
were infected immediately following catheter implantation with 50 l of 2  107 CFU of bacteria in PBS
introduced into the bladder lumen by transurethral inoculation as previously described (21). To harvest
the catheters and organs, mice were sacrificed at 3 days postinfection by cervical dislocation after
anesthesia inhalation; the silicone catheter, bladder, and kidneys were aseptically harvested. The
Washington University Animal Studies Committee approved all mouse infections and procedures as part
of protocol number 20150226. All animal care was consistent with the Guide for the Care and Use of
Laboratory Animals from the National Research Council (52).
Biofilm formation in human urine. For assessment of biofilm formation on fibrinogen-coated
96-well polystyrene plates (Grenier CellStar), wells were coated overnight at 4°C with 100 g ml1 human
fibrinogen free of plasminogen and von Willebrand factor (Enzyme Research Laboratory). The next day,
E. faecalis cultures grown overnight were diluted to an OD600 of 0.2 in BHI broth. The diluted cultures
were centrifuged, washed three times with 1 PBS, and diluted 1:100 in urine supplemented with 20 mg
ml1 BSA. Bacterial cells were allowed to attach to the fibrinogen-coated plate at 37°C under static
conditions as described previously (29, 53). After 24 h, microplates were washed with PBS to remove
unbound bacteria, and biofilm formation was assessed by staining wells with crystal violet as previously
described (53). Excess dye was removed by rinsing with sterile water, and the plates were then allowed
to dry at room temperature. Biofilms were resuspended with 200 l of 33% acetic acid, and the
absorbance at 595 nm was measured on a microplate reader (Molecular Devices). Experiments were
performed independently in triplicate per condition and per experiment.
Presence of EbpA on the cell surface of (p)ppGpp- and CodY-deficient strains. Surface expres-
sion of EbpA by E. faecalis OG1RF and derivatives was determined by an ELISA as previously described
(23). Bacterial strains were grown for 18 h in urine supplemented with 20 mg ml1 of BSA. Next, bacterial
cells were washed (3 times) with PBS, normalized to an OD600 of 0.5, resuspended with 50 mM carbonate
buffer (pH 9.6) containing 0.1% sodium azide, and used (100 l) to coat Immulon 4HBX microtiter plates
overnight at 4°C. The next day, plates were washed 3 times with PBS containing 0.05% Tween 20 (PBS-T)
to remove unbound bacteria and blocked for 2 h with 1.5% BSA– 0.1% sodium azide–PBS, followed by
three washes with PBS-T. EbpA surface expression was detected using mouse anti-EbpAFull antiserum,
which was diluted 1:100 in dilution buffer (PBS with 0.05% Tween 20, 0.1% BSA, and 0.5% methyl--D-
mannopyranoside) before serial dilutions were performed. A 100-l volume was added to the plate, and
the reaction mixture was incubated for 2 h. Subsequently, plates were washed with PBS-T, incubated for
1 h with horseradish peroxidase (HRP)-conjugated goat anti-rabbit antiserum (1:2,000), and washed again
with PBS-T. Detection was performed using a TMB (3,3=,5,5=-tetramethylbenzidine) substrate reagent set
(BD). The reaction mixtures were incubated for 5 min to allow color to develop, and the reactions were
then stopped by the addition of 1.0 M sulfuric acid. The absorbance was determined at 450 nm. Titers
were defined by the last dilution with an A450 of at least 0.2. As an additional control, rabbit anti-
Streptococcus group D antiserum was used to verify that whole cells of all strains were bound to the
microtiter plates at similar levels. EbpA expression titers were normalized against the bacterial titers at
the same dilution.
RNA-seq analysis. Cells grown in FMCG medium to an OD600 of 0.3 were collected by centrifugation
at 4,000 rpm for 20 min at 4°C and resuspended in 4 ml of a sterile RNA-stabilizing solution [3.5 M
(NH4)2SO4, 16.6 mM sodium citrate, and 13.3 mM EDTA, adjusted to a pH of 5.2 with H2SO4]. After a
10-min incubation at room temperature, cells were centrifuged at 4,000 rpm for 30 min at 4°C, and pellets
were stored at 80°C. RNA was extracted using the hot acid-phenol-chloroform method as previously
described (54). Subsequently, precipitated RNA was treated once with DNase I (Ambion, Carlsbad, CA),
followed by a second DNase I treatment using the DNA-free kit (Ambion) to completely remove DNA,
divalent cations, and traces of the DNase I enzyme. RNA concentrations were quantified with the
NanoDrop 1000 spectrophotometer (NanoDrop, Wilmington, DE), and RNA quality was assessed with the
Agilent bioanalyzer (Agilent, Santa Clara, CA). RNA-seq, data processing, and statistical analysis were
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performed at the University of Rochester Genomics Research Center (UR-GRC) using the Illumina platform
as previously described (55).
Real-time quantitative PCR analysis. Cultures were pelleted at 2,500 rpm for 8 min at 4°C. The
bacterial pellets were resuspended in 1 ml of RNA protect and incubated for 5 min at room temperature,
followed by centrifugation at 2,500 rpm for 8 min at 4°C. At that point, the bacterial pellets were kept at
80°C until ready for RNA extraction. Cells were resuspended in TE buffer (10 mM Tris Cl [pH 8], 1 mM
EDTA) and 10% SDS and homogenized for three 30-s cycles, with 2 min on ice between cycles. The
nucleic acids were retrieved from the total protein by phenol-chloroform (5:1) extraction. The inorganic
phase was resuspended in 0.7 ml RLT buffer (Qiagen) supplemented with 1% -mercaptoethanol, and
RNA was purified using an RNeasy minikit (Qiagen), including the on-column DNase treatment recom-
mended by the supplier. To further reduce DNA contamination, RNA samples were treated with DNase
I (Ambion) at 37°C for 30 min and repurified using the RNeasy minikit (Qiagen). RNA concentrations were
determined using the NanoDrop spectrophotometer. Reverse transcription and real-time PCR were
carried out according to protocols described previously (54), using the primer sets indicated in Table S4
in the supplemental material.
Statistical analysis. Data sets were analyzed using GraphPad Prism 6.0 software unless otherwise
noted. Log10-transformed CFU values from urine growth curves were analyzed via two-way analysis of
variance (ANOVA) followed by a comparison posttest. For CAUTI experiments, biofilm assays, and EbpA
ELISAs, a two-tailed Mann-Whitney U test was performed. RNA-seq processing and the subsequent
statistical analysis were performed at UR-GRC as previously described (55). qPCR data were analyzed by
Student’s t test and ANOVA with a multiple-comparison test.
Data availability. Gene expression data have been deposited in the NCBI Gene Expression Omnibus
(GEO) database under GEO series accession number GSE131749.
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